SCHEMBL24085650

SCHEMBL24085650

C[C@H](CCC(C)(C)O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3C(O)C[C@]12C

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GRIN1 Q05586 8/20 0.76
▸ GRIN2A Q12879 7/20 0.76
▸ GRIN2B Q13224 7/20 0.76
▸ NR1H3 Q13133 5/20 0.69
▸ OSBP P22059 4/20 0.69
▸ RORC P51449 4/20 0.69
▸ OSBP2 Q969R2 3/20 0.69
▸ CRYAB P02511 1/20 0.69
▸ HMGCR P04035 1/20 0.69
▸ ITGB3 P05106 1/20 0.69
▸ ITGAV P06756 1/20 0.69
▸ SREBF2 Q12772 1/20 0.69
▸ NPC1L1 Q9UHC9 1/20 0.69
▸ PTPN1 P18031 2/20 0.60
▸ USP2 O75604 1/20 0.57
▸ LMNA P02545 1/20 0.57
▸ ABCB1 P08183 1/20 0.57
▸ CYP46A1 Q9Y6A2 1/20 0.57
▸ DHCR24 Q15392 1/20 0.56
▸ EPHA2 P29317 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22446752 1.00 GRIN1 (0.76) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL8336467 0.88 RORC (0.74) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL6391972 0.88 RORC (0.74) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL6387555 0.88 RORC (0.74) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL6387062 0.88 RORC (0.74) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL8336472 0.88 RORC (0.74) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL6388729 0.88 RORC (0.74) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL14770941 0.87 GRIN1 (1.00) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL14771158 0.87 GRIN1 (1.00) GRIN1GRIN2AGRIN2BNR1H3OSBP
SCHEMBL19506256 0.87 GRIN1 (1.00) GRIN1GRIN2AGRIN2BNR1H3OSBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023114224-A1 COMBINATION OF MUSCARINIC RECEPTOR POSITIVE MODULATORS AND NMDA POSITIVE ALLOSTERIC MODULATORS SAGE THERAPEUTICS, INC. (US) 2023-06-22 — — WO disclosed
EP-3919502-A1 11-SUBSTITUTED 24-HYDROXYSTEROLS FOR USE IN THE TREATMENT OF NMDA RELATED CONDITIONS Sage Therapeutics, Inc. (US) 2021-12-08 — — EP disclosed
Send feedback